Literature DB >> 10790883

Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury.

L W Yick1, W Wu, K F So, H K Yip, D K Shum.   

Abstract

We examined whether enzymatic digestion of chondroitin sulfate (CS) promoted the axonal regeneration of neurons in Clarke's nucleus (CN) into a peripheral nerve (PN) graft following injury of the spinal cord. After hemisection at T11, a segment of PN graft was implanted at the lesion site. Either vehicle, brain-derived neurotrophic factor (BDNF) or chondroitinase ABC was applied at the implantation site. The postoperative survival period was 4 weeks. Treatment with vehicle or BDNF did not promote the axonal regeneration of CN neurons into the PN graft. Application of 2.5 unit/ml chondroitinase ABC resulted in a significant increase (12.8%) in the number of regenerated CN neurons. Double labeling with Fluoro-Gold and NADPH-diaphorase histochemistry showed that the regenerated CN neurons did not express nitric oxide synthase (NOS). Our results suggest that CS is inhibitory to the regeneration of CN neurons following injury of the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790883     DOI: 10.1097/00001756-200004070-00032

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  29 in total

Review 1.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

Review 2.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

3.  Aggrecan is expressed by embryonic brain glia and regulates astrocyte development.

Authors:  Miriam S Domowicz; Timothy A Sanders; Clifton W Ragsdale; Nancy B Schwartz
Journal:  Dev Biol       Date:  2008-01-22       Impact factor: 3.582

4.  Feasible stabilization of chondroitinase abc enables reduced astrogliosis in a chronic model of spinal cord injury.

Authors:  Andrea Raspa; Edoardo Bolla; Claudia Cuscona; Fabrizio Gelain
Journal:  CNS Neurosci Ther       Date:  2018-05-31       Impact factor: 5.243

5.  Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system.

Authors:  Noreen Bukhari; Luisa Torres; John K Robinson; Stella E Tsirka
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 6.  The chemical neurobiology of carbohydrates.

Authors:  Heather E Murrey; Linda C Hsieh-Wilson
Journal:  Chem Rev       Date:  2008-05-02       Impact factor: 60.622

Review 7.  Axonal growth therapeutics: regeneration or sprouting or plasticity?

Authors:  William B J Cafferty; Aaron W McGee; Stephen M Strittmatter
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

8.  Repellent guidance of regenerating optic axons by chondroitin sulfate glycosaminoglycans in zebrafish.

Authors:  Catherina G Becker; Thomas Becker
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 9.  A systematic review of directly applied biologic therapies for acute spinal cord injury.

Authors:  Brian K Kwon; Elena B Okon; Ward Plunet; Darryl Baptiste; Karim Fouad; Jessica Hillyer; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-06-16       Impact factor: 5.269

10.  tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2.

Authors:  Westley B Nolin; Jaime Emmetsberger; Noreen Bukhari; Yan Zhang; Joel M Levine; Stella E Tsirka
Journal:  Glia       Date:  2008-01-15       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.